ArticleBioTechniques2022

Validation of CRISPR targeting for proliferation and cytarabine resistance control genes in the acute myeloid leukemia cell line MOLM-13.

Subhash C Prajapati et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.